Search Results - "Liu, Jiannong"

Refine Results
  1. 1

    Survival in Daily Home Hemodialysis and Matched Thrice-Weekly In-Center Hemodialysis Patients by WEINHANDL, Eric D, JIANNONG LIU, GILBERTSON, David T, ARNESON, Thomas J, COLLINS, Allan J

    “…Frequent hemodialysis improves cardiovascular surrogates and quality-of-life indicators, but its effect on survival remains unclear. We used a matched-cohort…”
    Get full text
    Journal Article
  2. 2

    An improved comorbidity index for outcome analyses among dialysis patients by Liu, Jiannong, Huang, Zhi, Gilbertson, David T., Foley, Robert N., Collins, Allan J.

    Published in Kidney international (01-01-2010)
    “…Since comorbid conditions are highly prevalent among patients with end-stage renal disease, indexes measuring them have been widely used to describe the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis by Wetmore, James B, Guo, Haifeng, Liu, Jiannong, Collins, Allan J, Gilbertson, David T

    Published in Kidney international (01-10-2016)
    “…The incidence and period prevalence of glomerulonephritis (GN) with resultant rates of death and end-stage renal disease (ESRD) in the United States are…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US by Mues, Katherine E, Liede, Alexander, Liu, Jiannong, Wetmore, James B, Zaha, Rebecca, Bradbury, Brian D, Collins, Allan J, Gilbertson, David T

    Published in Clinical epidemiology (01-01-2017)
    “…Medicare is the federal health insurance program for individuals in the US who are aged ≥65 years, select individuals with disabilities aged <65 years, and…”
    Get full text
    Journal Article
  8. 8

    Trends in Hip Fracture Rates in US Hemodialysis Patients, 1993-2010 by Arneson, Thomas J., MD, Li, Shuling, MS, Liu, Jiannong, PhD, Kilpatrick, Ryan D., PhD, Newsome, Britt B., MD, St. Peter, Wendy L., PharmD

    Published in American journal of kidney diseases (01-10-2013)
    “…Background Changes in mineral and bone disorder treatment patterns and demographic changes in the dialysis population may have influenced hip fracture rates in…”
    Get full text
    Journal Article
  9. 9

    Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease by CHARYTAN, David M, SHULING LI, JIANNONG LIU, HERZOG, Charles A

    Published in Circulation (New York, N.Y.) (11-09-2012)
    “…Revascularization by coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI) is frequently deferred in patients with chronic…”
    Get full text
    Conference Proceeding Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population by Gilbertson, David T, Rothman, Kenneth J, Chertow, Glenn M, Bradbury, Brian D, Brookhart, M Alan, Liu, Jiannong, Winkelmayer, Wolfgang C, Stürmer, Til, Monda, Keri L, Herzog, Charles A, Ashfaq, Akhtar, Collins, Allan J, Wetmore, James B

    “…Morbidity and mortality vary seasonally. Timing and severity of influenza seasons contribute to those patterns, especially among vulnerable populations such as…”
    Get full text
    Journal Article
  14. 14

    Predialysis Health, Dialysis Timing, and Outcomes among Older United States Adults by CREWS, Deidra C, SCIALLA, Julia J, SHAFI, Tariq, MEYER, Klemens B, WU, Albert W, POWE, Neil R, BOULWARE, L. Ebony, JIANNONG LIU, HAIFENG GUO, BANDEEN-ROCHE, Karen, EPHRAIM, Patti L, JAAR, Bernard G, SOZIO, Stephen M, MISKULIN, Dana C, TANGRI, Navdeep

    “…Studies of dialysis initiation timing have not accounted for predialysis clinical factors that could impact postdialysis outcomes. We examined the association…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform by Chertow, Glenn M, Liu, Jiannong, Monda, Keri L, Gilbertson, David T, Brookhart, M Alan, Beaubrun, Anne C, Winkelmayer, Wolfgang C, Pollock, Allan, Herzog, Charles A, Ashfaq, Akhtar, Sturmer, Til, Rothman, Kenneth J, Bradbury, Brian D, Collins, Allan J

    “…Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anemia in patients with CKD, including those receiving dialysis, although clinical trials…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Projecting the number of patients with end-stage renal disease in the united states to the year 2015 by GILBERTSON, David T, JIANNONG LIU, XUE, Jay L, LOUIS, Thomas A, SOLID, Craig A, EBBEN, James P, COLLINS, Allan J

    “…The size of the prevalent ESRD population in the United States increased dramatically during the 1990s, from 196,000 in 1991 to 382,000 in 2000. Incidence also…”
    Get full text
    Journal Article
  20. 20

    Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies by Liu, Jiannong, Weinhandl, Eric D, Gilbertson, David T, Collins, Allan J, St Peter, Wendy L

    Published in Kidney international (01-02-2012)
    “…In observational studies, treatment is often time dependent. Mishandling the time from the beginning of follow-up to treatment initiation can result in bias…”
    Get more information
    Journal Article